Collagen Signaling via DDR1 Exacerbates Barriers to Macromolecular Drug Delivery in a 3D Model of Pancreatic Cancer Fibrosis
Small · 2025
DOI: 10.1002/smll.202506926 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Mayu Ohira und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biomedicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka…. Hauptthemen laut MEDLINE: Discoidin Domain Receptor 1, Pancreatic Neoplasms, Signal Transduction, Drug Delivery Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Okayama University, Harmonic Ito Foundation.
Abstract (Originalsprache)
Fibrosis is a significant barrier to drug delivery in pancreatic ductal adenocarcinoma (PDAC) and contributes to its dismal prognosis. Pancreatic stellate cells (PSCs) drive fibrosis by excessively secreting extracellular matrix proteins such as collagen I. Collagen I is thought to physically obstruct the delivery of macromolecules, such as albumin, antibodies, and nanomedicines. Apart from its structural role, collagen signals through dedicated cell surface receptors, such as the discoidin domain receptors (DDR) 1/2. However, whether and how collagen signaling contributes to fibrotic barrier generation remains uncharacterized. Here, a 3D culture model of PDAC fibrosis constructed from patient PSCs is used to assess the contribution of DDR1/2‐mediated collagen signaling. DDR1/2 inhibition diminishes collagen I expression in PSCs to enhance macromolecular delivery. Moreover, MEK inhibitors exacerbate the fibrotic barrier by up‐regulating collagen I, an effect reversed by inhibiting DDR1/2. Through isoform‐specific targeting, inhibiting DDR1, but not DDR2, is shown to be effective. Downstream of DDR, the involvement of the PI3K/AKT/mTOR pathway is demonstrated, particularly alternative mTOR complexes involving MEAK7 and GIT1. Altogether, the results show in vitro that DDR1‐mediated collagen signaling exacerbates the fibrotic barrier and may be targeted to enhance macromolecular drug delivery in PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Biomedicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka, Kita-Ku, Okayama-Shi, Okayama, 700-8530, Japan.
- Department of Pharmaceutical Biomedicine, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, 1-1-1 Tsushima-naka, Kita-Ku, Okayama-Shi, Okayama, 700-8530, Japan.
- Biomaterials Field, Research Center for Macromolecules and Biomaterials, National Institute for Materials Science, 1-1 Namiki, Tsukuba-Shi, Ibaraki, 305-0044, Japan.
- Department of Materials Processing, Graduate School of Engineering, Tohoku University, 6-6-02, Aza-Aoba Aramaki, Aoba-Ku, Sendai-Shi, Miyagi, 980-8579, Japan.
- Division of Biomedical Engineering for Diagnosis and Treatment, Graduate School of Biomedical Engineering, Tohoku University, 6-6-02, Aza-Aoba Aramaki, Aoba-Ku, Sendai-Shi, Miyagi, 980-8579, Japan.
- Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Sciences and Technology (QST), 4-9-1 Anagawa, Inage-Ku, Chiba-Shi, Chiba, 263-8555, Japan.
ORCID-Profile: Mitsunobu R Kano, Hiroyoshi Y Tanaka
Förderung
- Japan Society for the Promotion of Science
- Okayama University
- Harmonic Ito Foundation
- Inamori Foundation
- Hokuto Foundation for Bioscience
- Research Foundation for Pharmaceutical Sciences
- Japan Foundation for Applied Enzymology
- Pancreas Research Foundation of Japan
Zitieren
APA
Ohira, M., Kitamura, M., Iwasaki, H., Ohta-Okano, H., Tsujii, H., Nakamura, R., Nakazawa, T., Nishiguchi, A., Yamamoto, M., Osada, K., Toyooka, S., Cabral, H., Masamune, A., Kano, M. R., & Tanaka, H. Y. (2025). Collagen Signaling via DDR1 Exacerbates Barriers to Macromolecular Drug Delivery in a 3D Model of Pancreatic Cancer Fibrosis. Small. https://doi.org/10.1002/smll.202506926
Vancouver
Ohira M, Kitamura M, Iwasaki H, Ohta-Okano H, Tsujii H, Nakamura R, et al. Collagen Signaling via DDR1 Exacerbates Barriers to Macromolecular Drug Delivery in a 3D Model of Pancreatic Cancer Fibrosis. Small. 2025. doi:10.1002/smll.202506926
BibTeX
@article{Ohira2025,
author = {Ohira, Mayu and Kitamura, Moe and Iwasaki, Hiroyo and Ohta-Okano, Haruko and Tsujii, Hiyori and Nakamura, Reika and Nakazawa, Takuya and Nishiguchi, Akihiro and Yamamoto, Masaya and Osada, Kensuke and Toyooka, Shinichi and Cabral, Horacio and Masamune, Atsushi and Kano, Mitsunobu R and Tanaka, Hiroyoshi Y},
title = {Collagen Signaling via DDR1 Exacerbates Barriers to Macromolecular Drug Delivery in a 3D Model of Pancreatic Cancer Fibrosis},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202506926}
}
EUVIMED